191 related articles for article (PubMed ID: 36145419)
21. Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii.
Ueno K; Kinjo Y; Okubo Y; Aki K; Urai M; Kaneko Y; Shimizu K; Wang DN; Okawara A; Nara T; Ohkouchi K; Mizuguchi Y; Kawamoto S; Kamei K; Ohno H; Niki Y; Shibuya K; Miyazaki Y
Infect Immun; 2015 Apr; 83(4):1577-86. PubMed ID: 25644007
[TBL] [Abstract][Full Text] [Related]
22. Phagosomal F-Actin Retention by Cryptococcus gattii Induces Dendritic Cell Immunoparalysis.
Jamil K; Polyak MJ; Feehan DD; Surmanowicz P; Stack D; Li SS; Ogbomo H; Olszewski M; Ganguly A; Mody CH
mBio; 2020 Nov; 11(6):. PubMed ID: 33234684
[No Abstract] [Full Text] [Related]
23. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs.
Zhang Y; Wang F; Bhan U; Huffnagle GB; Toews GB; Standiford TJ; Olszewski MA
Am J Pathol; 2010 Aug; 177(2):754-65. PubMed ID: 20581055
[TBL] [Abstract][Full Text] [Related]
24. Dendritic Cell-Based Vaccine Against Fungal Infection.
Ueno K; Urai M; Ohkouchi K; Miyazaki Y; Kinjo Y
Methods Mol Biol; 2016; 1403():537-49. PubMed ID: 27076152
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant Curdlan Contributes to Immunization against
Oliveira-Brito PKM; de Campos GY; Guimarães JG; Serafim da Costa L; Silva de Moura E; Lazo-Chica JE; Roque-Barreira MC; da Silva TA
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455369
[TBL] [Abstract][Full Text] [Related]
26. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
Nyazika TK; Hagen F; Meis JF; Robertson VJ
J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
[TBL] [Abstract][Full Text] [Related]
27. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
28. X-linked immunodeficient (XID) mice exhibit high susceptibility to Cryptococcus gattii infection.
Diniz-Lima I; da Rosa PR; da Silva-Junior EB; Guimarães-de-Oliveira JC; de Freitas EO; de Oliveira Nascimento D; Morrot A; Nimrichter L; Previato JO; Mendonça-Previato L; Freire-de-Lima L; Decote-Ricardo D; Freire-de-Lima CG
Sci Rep; 2021 Sep; 11(1):18397. PubMed ID: 34526536
[TBL] [Abstract][Full Text] [Related]
29. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
30. Cryptococcus gattii Complex Infections in HIV-Infected Patients, Southeastern United States.
Bruner KT; Franco-Paredes C; Henao-Martínez AF; Steele GM; Chastain DB
Emerg Infect Dis; 2018 Nov; 24(11):1998-2002. PubMed ID: 30334702
[TBL] [Abstract][Full Text] [Related]
31. Cryptococcus gattii alters immunostimulatory potential in response to the environment.
Ueno K; Otani Y; Yanagihara N; Nakamura T; Shimizu K; Yamagoe S; Miyazaki Y
PLoS One; 2019; 14(8):e0220989. PubMed ID: 31398236
[TBL] [Abstract][Full Text] [Related]
32. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
33. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
34. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice.
Chaturvedi AK; Hameed RS; Wozniak KL; Hole CR; Leopold Wager CM; Weintraub ST; Lopez-Ribot JL; Wormley FL
PLoS One; 2014; 9(8):e104316. PubMed ID: 25119981
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.
Hsiao HB; Chou AH; Lin SI; Chen IH; Lien SP; Liu CC; Chong P; Liu SJ
J Virol; 2014 Oct; 88(20):11658-70. PubMed ID: 25078697
[TBL] [Abstract][Full Text] [Related]
36. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
37. Meningitis Due to Cryptococcus gattii in an Immunocompetent Patient.
Patil RT; Sangwan J; Juyal D; Lathwal S
J Clin Diagn Res; 2013 Oct; 7(10):2274-5. PubMed ID: 24298497
[TBL] [Abstract][Full Text] [Related]
38. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii.
Minns LA; Menard LC; Foureau DM; Darche S; Ronet C; Mielcarz DW; Buzoni-Gatel D; Kasper LH
J Immunol; 2006 Jun; 176(12):7589-97. PubMed ID: 16751405
[TBL] [Abstract][Full Text] [Related]
39. Immunization with Antigen-Pulsed Dendritic Cells Against Highly Virulent Cryptococcus gattii Infection: Analysis of Cytokine-Producing T Cells.
Ueno K; Urai M; Takatsuka S; Abe M; Miyazaki Y; Kinjo Y
Methods Mol Biol; 2017; 1625():327-339. PubMed ID: 28585000
[TBL] [Abstract][Full Text] [Related]
40. Calcineurin governs thermotolerance and virulence of Cryptococcus gattii.
Chen YL; Lehman VN; Lewit Y; Averette AF; Heitman J
G3 (Bethesda); 2013 Mar; 3(3):527-39. PubMed ID: 23450261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
